• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION CLEARLINK/CONTINU-FLO; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION CLEARLINK/CONTINU-FLO; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number 2R8519
Medical Device Problem Codes Volume Accuracy Problem (1675); Material Twisted/Bent (2981)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Should additional relevant information become available, a supplemental report will be submitted.
 
Event or Problem Description
It was reported there were flow rate accuracy issues while using an unspecified quantity of clearlink non-dehp continu-flo solution sets.The flow rate inaccuracies were observed when running at a maximum rate of 1200 ml/hr; there was significant residual fluid in the bags.This was identified during patient infusions in the intensive care unit (icu).The residual was noticed with primary or secondary infusions on different pumps, different users, and different medications.This event would often be noticed following lengthy infusions running at keep vein open (kvo) 10 ml/hr followed by a flow rate increase to 1200 ml/hr (other times using the bolus key).The tubing in all cases were loaded correctly and were observed to have significant kinks at where the pinch clamps occlude the line within the pumping mechanism.They also reported that by reposing the tubing before increasing the rate (or after bolus complete) resulted in significantly improved accuracy.There was no report of patient injury or medical intervention associated with this event.No additional information is available.
 
Additional Manufacturer Narrative
Additional information was added to h6.H11: the device was not returned and the lot number is unknown; therefore, a device analysis could not be completed.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLEARLINK/CONTINU-FLO
Common Device Name
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
Manufacturer (Section G)
BAXTER HEALTHCARE - CARTAGO
600 mts oeste de entrada
las americas parque industrial
cartago 30106
CS   30106
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 60073
2242702068
MDR Report Key22018861
Report Number1416980-2025-02829
Device Sequence Number9411796
Product Code FPA
UDI-Device Identifier00085412565682
UDI-Public(01)00085412565682
Combination Product (Y/N)N
Initial Reporter CountryCA
PMA/510(K) Number
K180739
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,User Facility,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 06/13/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Model Number2R8519
Device Catalogue Number2R8519
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/15/2025
Supplement Date Received by Manufacturer06/10/2025
Initial Report FDA Received Date05/14/2025
Supplement Report FDA Received Date06/13/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
NOVUM IQ LVP; UNSPECIFIED MEDICATION
Patient SexUnknown
-
-